In the present study, we provide evidence that IL-33 exacerbates antigen-induced asthmatic responses, including airway hyperresponsiveness, inflammation and remodeling, mast cell activation, production of IgE and cytokines including IL-4, IL-5 and IL-13, and accumulation of pulmonary ILC2s. Here, IL33 is linked to airway hyperresponsiveness.